Hologic to buy Cynosure to expand into medical aesthetics

Hologic Inc said on Tuesday it would acquire medical aesthetics company Cynosure Inc for $1.65 billion as it looks to capitalize on an increase in medical procedures that are not traditionally reimbursed. The medical aesthetics market is growing at a rapid pace as the American population ages and more effective non-surgical products become widely available, leading to a spurt in dealmaking in the sector. Cynosure – which makes products used in non-invasive body contouring, hair removal, skin revitalization and women’s health – has generated double-digit revenue growth for seven straight years.
Go to Source

Scientists soften on DNA editing of human eggs, sperm, embryos: report

A file photo of a DNA double helix in an undated artist's illustration released by the National Human Genome Research Institute to ReutersBy Julie Steenhuysen CHICAGO (Reuters) – Although not ready yet, powerful gene editing tools may one day be used on human embryos, eggs and sperm to remove genes that cause inherited diseases, according to a report by U.S. scientists and ethicists released on Tuesday. The report from the National Academy of Sciences (NAS) and the National Academy of Medicine said scientific advances make gene editing in human reproductive cells "a realistic possibility that deserves serious consideration.” The statement signals a softening in approach over the use of the technology known as CRISPR-Cas9, which has opened up new frontiers in genetic medicine because of its ability to modify genes quickly and efficiently. In December 2015, scientists and ethicists at an international meeting held at the NAS in Washington said it would be "irresponsible" to use gene editing technology in human embryos for therapeutic purposes, such as to correct genetic diseases, until safety and efficacy issues are resolved.

Go to Source

1 4 5 6 7 8 11